Palliative care in heart failure: a position statement from the palliative care workshop of the Heart Failure Association of the European Society of Cardiology.

PubWeight™: 1.86‹?› | Rank: Top 3%

🔗 View Article (PMID 19386813)

Published in Eur J Heart Fail on May 01, 2009

Authors

Tiny Jaarsma1, James M Beattie, Mary Ryder, Frans H Rutten, Theresa McDonagh, Paul Mohacsi, Scott A Murray, Thomas Grodzicki, Ingrid Bergh, Marco Metra, Inger Ekman, Christiane Angermann, Marcia Leventhal, Antonis Pitsis, Stefan D Anker, Antonello Gavazzi, Piotr Ponikowski, Kenneth Dickstein, Etienne Delacretaz, Lynda Blue, Florian Strasser, John McMurray, Advanced Heart Failure Study Group of the HFA of the ESC

Author Affiliations

1: Department of Cardiology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands. t.jaarsma@thorax.umcg.nl

Articles citing this

Heart failure in elderly patients: distinctive features and unresolved issues. Eur J Heart Fail (2013) 1.66

End-of-life care conversations with heart failure patients: a systematic literature review and narrative synthesis. Br J Gen Pract (2011) 1.42

Translating and testing the ENABLE: CHF-PC concurrent palliative care model for older adults with heart failure and their family caregivers. J Palliat Med (2014) 1.41

Understanding the epidemic of heart failure: past, present, and future. Curr Heart Fail Rep (2014) 1.12

Early identification of palliative care patients in general practice: development of RADboud indicators for PAlliative Care Needs (RADPAC). Br J Gen Pract (2012) 1.12

Palliative medicine consultation for preparedness planning in patients receiving left ventricular assist devices as destination therapy. Mayo Clin Proc (2011) 1.11

The effect of intravenous ferric carboxymaltose on health-related quality of life in patients with chronic heart failure and iron deficiency: a subanalysis of the FAIR-HF study. Eur Heart J (2012) 1.08

Identifying acute coronary syndrome patients approaching end-of-life. PLoS One (2012) 1.03

Giving voice to patients' and family caregivers' needs in chronic heart failure: implications for palliative care programs. J Palliat Med (2011) 1.03

Agents with inotropic properties for the management of acute heart failure syndromes. Traditional agents and beyond. Heart Fail Rev (2009) 1.02

Iron deficiency is a key determinant of health-related quality of life in patients with chronic heart failure regardless of anaemia status. Eur J Heart Fail (2013) 0.99

End-of-life planning in heart failure: it should be the end of the beginning. Can J Cardiol (2010) 0.96

Treatment for chronic heart failure in the elderly: current practice and problems. Heart Fail Rev (2013) 0.93

Training general practitioners in early identification and anticipatory palliative care planning: a randomized controlled trial. BMC Fam Pract (2015) 0.93

Palliative care consultations for heart failure patients: how many, when, and why? J Card Fail (2013) 0.90

Impaired health status and care dependency in patients with advanced COPD or chronic heart failure. Qual Life Res (2011) 0.89

Patient, carer and professional perspectives on barriers and facilitators to quality care in advanced heart failure. PLoS One (2014) 0.87

Integrated palliative care in Europe: a qualitative systematic literature review of empirically-tested models in cancer and chronic disease. BMC Palliat Care (2016) 0.87

Development of a heart failure filter for Medline: an objective approach using evidence-based clinical practice guidelines as an alternative to hand searching. BMC Med Res Methodol (2011) 0.87

Towards integration of palliative care in patients with chronic heart failure and chronic obstructive pulmonary disease: a systematic literature review of European guidelines and pathways. BMC Palliat Care (2016) 0.87

Management of chronic heart failure in the older population. J Geriatr Cardiol (2014) 0.86

Palliative care among heart failure patients in primary care: a comparison to cancer patients using English family practice data. PLoS One (2014) 0.86

The caregiving perspective in heart failure: a population based study. BMC Health Serv Res (2013) 0.83

Multidisciplinary intensive education in the hospital improves outcomes for hospitalized heart failure patients in a Japanese rural setting. BMC Health Serv Res (2014) 0.83

Physician attitudes toward palliative care for patients with pulmonary arterial hypertension: results of a cross-sectional survey. Pulm Circ (2014) 0.82

Understanding palliative care on the heart failure care team: an innovative research methodology. J Pain Symptom Manage (2012) 0.80

"Sometimes we can't fix things": a qualitative study of health care professionals' perceptions of end of life care for patients with heart failure. BMC Palliat Care (2016) 0.79

Adaptive practices in heart failure care teams: implications for patient-centered care in the context of complexity. J Multidiscip Healthc (2015) 0.79

"Everything They Were Discussing, We Were Already Doing": Hospice Heart Failure Caregivers Reflect on a Palliative Caregiving Intervention. J Hosp Palliat Nurs (2013) 0.79

Team-based Palliative and End-of-life Care for Heart Failure. Heart Fail Clin (2015) 0.79

Transition to palliative care when transcatheter aortic valve implantation is not an option: opportunities and recommendations. Curr Opin Support Palliat Care (2016) 0.78

Opioids for symptomatic therapy of dyspnoea in patients with advanced chronic heart failure--is there evidence? Wien Med Wochenschr (2009) 0.78

Effects of a transitional palliative care model on patients with end-stage heart failure: a randomised controlled trial. Heart (2016) 0.77

Type and course of symptoms demonstrated in the terminal and dying phases by people with dementia in nursing homes. Z Gerontol Geriatr (2015) 0.77

Managing futility in critically ill patients with cardiac disease. Nat Rev Cardiol (2013) 0.77

Comparing unmet needs between community-based palliative care patients with heart failure and patients with cancer. J Palliat Med (2014) 0.77

Palliative care needs in patients hospitalized with heart failure (PCHF) study: rationale and design. ESC Heart Fail (2015) 0.77

The causes, consequences, and treatment of left or right heart failure. Vasc Health Risk Manag (2011) 0.77

Outcome of patients admitted with acute coronary syndrome on palliative treatment: insights from the nationwide AMIS Plus Registry 1997-2014. BMJ Open (2015) 0.77

Barriers to goals of care discussions with hospitalized patients with advanced heart failure: feasibility and performance of a novel questionnaire. ESC Heart Fail (2016) 0.75

Effective communication and ethical consent in decisions related to ICDs. Nat Rev Cardiol (2011) 0.75

New role of ventricular assist devices as bridge to transplantation: European perspective. Curr Opin Organ Transplant (2017) 0.75

Effects of a transitional palliative care model on patients with end-stage heart failure: study protocol for a randomized controlled trial. Trials (2016) 0.75

End-of-life care in a cardiology department: have we improved? J Geriatr Cardiol (2016) 0.75

Heart failure in the elderly. J Geriatr Cardiol (2016) 0.75

Current challenges in palliative care provision for heart failure in the UK: a survey on the perspectives of palliative care professionals. Open Heart (2015) 0.75

Palliative care in heart failure: facts and numbers. ESC Heart Fail (2016) 0.75

Child ego state is associated with high prevalence of repeated hospitalizations in patients with heart failure. ESC Heart Fail (2015) 0.75

The gap between policy and practice: a systematic review of patient-centred care interventions in chronic heart failure. Heart Fail Rev (2015) 0.75

Effective management for older people with heart failure: from acute to palliative care paradigms. J Geriatr Cardiol (2016) 0.75

Symptom burden in heart failure: assessment, impact on outcomes, and management. Heart Fail Rev (2017) 0.75

[Tools for optimizing pharmacotherapy for geriatric patients with multimorbidity at the end of life: helpful oder just raising awareness?]. Wien Med Wochenschr (2014) 0.75

Articles by these authors

2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens (2007) 20.09

ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J (2012) 18.18

Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Eur Heart J (2010) 16.39

ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur Heart J (2012) 16.00

Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial. Lancet (2008) 13.34

2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J (2013) 12.73

ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur Heart J (2008) 12.32

Universal definition of myocardial infarction. Circulation (2007) 11.69

ACC/AHA/ESC 2006 Guidelines for the Management of Patients with Atrial Fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Circulation (2006) 11.49

ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail (2012) 10.38

How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology. Eur Heart J (2007) 10.38

Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trial. Lancet (2003) 9.80

Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary. The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD). Eur Heart J (2007) 9.80

2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology. Eur Heart J (2013) 9.54

2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J (2007) 9.43

Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction. N Engl J Med (2004) 9.13

Adaptive Servo-Ventilation for Central Sleep Apnea in Systolic Heart Failure. N Engl J Med (2015) 8.61

Third universal definition of myocardial infarction. J Am Coll Cardiol (2012) 8.59

Definition and classification of cancer cachexia: an international consensus. Lancet Oncol (2011) 7.78

Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. Eur Heart J (2005) 7.75

Cardiac-resynchronization therapy in heart failure with a narrow QRS complex. N Engl J Med (2013) 7.35

ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur J Heart Fail (2008) 6.80

Warfarin and aspirin in patients with heart failure and sinus rhythm. N Engl J Med (2012) 6.60

The Seattle Heart Failure Model: prediction of survival in heart failure. Circulation (2006) 6.58

Frailty consensus: a call to action. J Am Med Dir Assoc (2013) 6.54

Serelaxin, recombinant human relaxin-2, for treatment of acute heart failure (RELAX-AHF): a randomised, placebo-controlled trial. Lancet (2012) 6.42

Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Europace (2010) 6.31

2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: the Task Force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA). Eur Heart J (2013) 6.17

ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation). J Am Coll Cardiol (2006) 6.11

European guidelines on cardiovascular disease prevention in clinical practice: full text. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts). Eur J Cardiovasc Prev Rehabil (2007) 6.10

ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (writing committee to develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Circulation (2006) 5.95

ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death). J Am Coll Cardiol (2006) 5.81

Guidelines on the management of stable angina pectoris: executive summary: The Task Force on the Management of Stable Angina Pectoris of the European Society of Cardiology. Eur Heart J (2006) 5.79

Cachexia: a new definition. Clin Nutr (2008) 5.49

Ferric carboxymaltose in patients with heart failure and iron deficiency. N Engl J Med (2009) 5.34

2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur Heart J (2015) 5.24

Effects of high-dose versus low-dose losartan on clinical outcomes in patients with heart failure (HEAAL study): a randomised, double-blind trial. Lancet (2009) 5.23

ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: the Task Force on diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and developed in collaboration with the European Association for the Study of Diabetes (EASD). Eur Heart J (2013) 5.23

2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC). Eur Heart J (2014) 5.21

Developing primary palliative care. BMJ (2004) 5.08

EuroHeart Failure Survey II (EHFS II): a survey on hospitalized acute heart failure patients: description of population. Eur Heart J (2006) 4.57

Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome. N Engl J Med (2015) 4.56

Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS). Eur Heart J (2005) 3.89

Uric acid and survival in chronic heart failure: validation and application in metabolic, functional, and hemodynamic staging. Circulation (2003) 3.89

2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J (2016) 3.83

Results of a non-specific immunomodulation therapy in chronic heart failure (ACCLAIM trial): a placebo-controlled randomised trial. Lancet (2008) 3.71

Adherence to candesartan and placebo and outcomes in chronic heart failure in the CHARM programme: double-blind, randomised, controlled clinical trial. Lancet (2005) 3.67

Living and dying with severe chronic obstructive pulmonary disease: multi-perspective longitudinal qualitative study. BMJ (2011) 3.61

Heart failure with preserved left ventricular systolic function; epidemiology, clinical characteristics, and prognosis. J Am Coll Cardiol (2004) 3.58

Cardio-renal syndromes: report from the consensus conference of the acute dialysis quality initiative. Eur Heart J (2009) 3.52

ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: full text: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 guidelines for the management of patients with atrial fibrillation) developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Europace (2006) 3.52

Executive summary of the guidelines on the diagnosis and treatment of acute heart failure: the Task Force on Acute Heart Failure of the European Society of Cardiology. Eur Heart J (2005) 3.50

Digoxin reduces 30-day all-cause hospital admission in older patients with chronic systolic heart failure. Am J Med (2013) 3.46

Palliative cancer care a decade later: accomplishments, the need, next steps -- from the American Society of Clinical Oncology. J Clin Oncol (2009) 3.36

State of the art: using natriuretic peptide levels in clinical practice. Eur J Heart Fail (2008) 3.35

Effect of carvedilol on the morbidity of patients with severe chronic heart failure: results of the carvedilol prospective randomized cumulative survival (COPERNICUS) study. Circulation (2002) 3.34

Expert consensus document on beta-adrenergic receptor blockers. Eur Heart J (2004) 3.14

Concern Guidelines for pre-operative cardiac risk assessment and perioperative cardiac management in non-cardiac surgery. Eur Heart J (2009) 3.14

ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death) developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Europace (2006) 3.11

State of the science: promoting self-care in persons with heart failure: a scientific statement from the American Heart Association. Circulation (2009) 3.05

The effect of micronutrient supplementation on quality-of-life and left ventricular function in elderly patients with chronic heart failure. Eur Heart J (2005) 2.92

2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail (2016) 2.91